NCT04851275

Brief Summary

In this study, the investigators show that by upskilling of primary care physicians (PCPs) in SDM and leveraging on a novel pictorial Visual Analogue Uroflowmetry Score (VAUS), they can enhance older men's recognition of LUTS and stimulated discussion with their PCPs.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 15, 2019

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2019

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2020

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

March 26, 2021

Completed
25 days until next milestone

First Posted

Study publicly available on registry

April 20, 2021

Completed
Last Updated

April 20, 2021

Status Verified

March 1, 2021

Enrollment Period

8 months

First QC Date

March 26, 2021

Last Update Submit

April 16, 2021

Conditions

Outcome Measures

Primary Outcomes (2)

  • Quality of the decision on the management of lower urinary tract symptoms from the patients' perspective

    The Shared Decision Making-9 (SDMQ9) Questionnaire measures decision quality from the perspective of the patient. Nine individual items in the questionnaire is scored from 0 to 5 on a six-point Likert scale ranging from 0 ("completely disagree") to 5 ("completely agree"). Standard scoring for the full scale is the total score, with values from 0 to 45. Higher scores indicate higher quality decisions.

    Through study completion, an average of 6 months

  • Quality of the decision on the management of lower urinary tract symptoms from the physicians' perspective

    The Shared Decision Making-Doctor (SDMQDoc) Questionnaire measures decision quality from the perspective of the physician. Nine individual items in the questionnaire is scored from 0 to 5 on a six-point Likert scale ranging from 0 ("completely disagree") to 5 ("completely agree"). Standard scoring for the full scale is the total score, with values from 0 to 45. Higher scores indicate higher quality decisions.

    Through study completion, an average of 6 months

Study Arms (2)

Shared decision making for men with lower urinary tract symptoms

EXPERIMENTAL

Participants used the Visual Analogue Uroflowmetry Score so report their symptoms and were attended by Primary Care Physicians trained in shared decision making

Behavioral: Physicians trained in shared decision making

No shared decision making for men with lower urinary tract symptoms

ACTIVE COMPARATOR

Participants did not use the Visual Analogue Uroflowmetry Score to report their symptoms and received usual care by Primary Care Physicians not trained in shared decision making

Behavioral: Physicians were not trained in shared decision making

Interventions

Physicians in this group were trained in shared decision making

Shared decision making for men with lower urinary tract symptoms

Physicians did not receive training in shared decision making

No shared decision making for men with lower urinary tract symptoms

Eligibility Criteria

Age50 Years+
Sexmale(Gender-based eligibility)
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • men aged 50 years old and older attending the polyclinic for routine follow up of a chronic disease (non-communicable disease)
  • have moderate-to-severe LUTS and/or poor quality of life (QOL) as assessed by the validated International Prostate Symptom Score (IPSS) of eight or more and/or its individual QOL score of three or more
  • men of any local Asian ethnicity and were willing to provide written consent
  • can communicate with their allocated PCP in either of the three main local languages; English, Mandarin or Malay.

You may not qualify if:

  • have indwelling catheters
  • urinary incontinence requiring diapers
  • anuria due to any renal pathology
  • gross hematuria
  • acute urinary retention
  • symptoms consistent with an acute urinary tract infection
  • existing treatment of LUTS or other prostate pathology
  • visual or hearing impairment which render men incapable of understanding the study procedure and providing informed consent
  • men unwilling to discuss their LUTS treatment options with their PCP

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Haidee Ngu

Singapore, 150167, Singapore

Location

Related Publications (1)

  • Tiwari R, Ng MY, Neo SH, Mangat R, Ho H. Prospective validation of a novel visual analogue uroflowmetry score (VAUS) in 1000 men with lower urinary tract symptoms (LUTS). World J Urol. 2020 May;38(5):1267-1273. doi: 10.1007/s00345-019-02909-1. Epub 2019 Aug 27.

    PMID: 31451932BACKGROUND

MeSH Terms

Conditions

Patient ParticipationPatient Preference

Condition Hierarchy (Ancestors)

Patient Acceptance of Health CareTreatment Adherence and ComplianceHealth BehaviorBehaviorPatient Satisfaction

Study Officials

  • Tan Ngiap Chuan, MBBS

    Singhealth polyclinic

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 26, 2021

First Posted

April 20, 2021

Study Start

April 15, 2019

Primary Completion

November 30, 2019

Study Completion

March 31, 2020

Last Updated

April 20, 2021

Record last verified: 2021-03

Data Sharing

IPD Sharing
Will not share

Locations